Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.14 - Radiotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
-
+
P1.14-018 - Construction and Evaluation of RapidPlanTM Models for Radical Lung Planning
09:30 - 09:30 | Presenter: Timothy Mitchell | Author(s): Y. Flanagan, P. Kelso, S. Smith
- Abstract
Loading...
-
+
P3.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P3.04-006 - SYSTEMS-2: Randomised Phase II Trial of Standard Versus Dose Escalated Radiotherapy for Pain in Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Miranda Jane Ashton | Author(s): N. O'Rourke, N. Macleod, S. Smith, R. Valentine, B. Laird, S. Sheridan, L. Alexander, A. Chalmers
- Abstract
Loading...
-
+
P3.09 - Mesothelioma
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
-
+
P3.09-002 - Can We Do Better? Feasibility Dosimetric Study for Upfront Radical Radiotherapy in Mesothelioma
09:30 - 09:30 | Presenter: Timothy Mitchell | Author(s): A. Cascales, W. Poon, Miranda Jane Ashton, S. Smith, R. Valentine, D. Kearns, S. Harrow
- Abstract
Loading...
-
+
OA 12 - Emerging Genomic Targets
- 11:00 - 12:30
- 10/18/2017
- Location: F203 + F204 (Annex Hall)
- Type: Oral
- Track: Advanced NSCLC
- Moderators:H. Akita, Maurice Pérol
-
+
OA 12.07 - LOXO-292, a Potent, Highly Selective RET Inhibitor, in MKI-Resistant RET Fusion-Positive Lung Cancer Patients with and without Brain Metastases
12:00 - 12:10 | Presenter: Vamsidhar Velcheti | Author(s): T.M. Bauer, V. Subbiah, M.E. Cabanillas, N. Lakhani, L.J. Wirth, Geoffrey R. Oxnard, M.H. Shah, E.J. Sherman, S. Smith, T. Eary, S. Cruickshank, B.B. Tuch, K. Ebata, M. Nguyen, S. Corsi-Travali, S. Rothenberg, Alexander Drilon
- Abstract
Loading...